Literature DB >> 31293153

Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis.

Ana García-Aguilar1, Inmaculada Martínez-Reyes1, José M Cuezva1.   

Abstract

The role played by protein turnover in metabolic reprogramming is unknown. Herein, using a SILAC approach, we have studied the changes in the half-life of 266 proteins of energy metabolism and of translation during the metabolic switch induced by the prolyl hydroxylases inhibitor dimethyloxalylglycine (DMOG). DMOG induces HIF-1α expression and triggers the activation of glycolysis and the concurrent inhibition of mitochondrial respiration in colon cancer cells. Changes in the activity of energy provision pathways correlated with increased turnover rates of glycolytic enzymes and the stabilization of mitochondrial proteins. Moreover, reprogramming also stabilized the proteins of translation. The partial DMOG-mediated arrest of the synthesis of mitochondrial and translation proteins results from the inhibition of the mTORC1/p70SK/S6 signaling pathway. In contrast, DMOG stimulated the synthesis of glycolytic enzymes, emphasizing the opposite and differential regulation of the two pathways of energy provision. Addition of MitoQ, a mitochondrial reactive oxygen species (mtROS) scavenger, stabilized the turnover of cellular proteins similarly as when protein degradation is inhibited with leupeptin, a serine-protease inhibitor. Overall, the results show that the higher the activity of a pathway the lower is the half-life of the proteins involved and suggest a role for mtROS in cellular proteostasis. Data are available via ProteomeXchange with identifier PXD013482.

Entities:  

Keywords:  ATP synthase; SILAC; glycolysis; mTORC1; mitochondrial ROS; prolyl hydroxylases

Year:  2019        PMID: 31293153     DOI: 10.1021/acs.jproteome.9b00239

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  4 in total

Review 1.  The ATPase Inhibitory Factor 1 is a Tissue-Specific Physiological Regulator of the Structure and Function of Mitochondrial ATP Synthase: A Closer Look Into Neuronal Function.

Authors:  Sonia Domínguez-Zorita; Inés Romero-Carramiñana; José M Cuezva; Pau B Esparza-Moltó
Journal:  Front Physiol       Date:  2022-03-18       Impact factor: 4.755

Review 2.  The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.

Authors:  Xingting Bao; Jinhua Zhang; Guomin Huang; Junfang Yan; Caipeng Xu; Zhihui Dou; Chao Sun; Hong Zhang
Journal:  Cell Death Dis       Date:  2021-02-26       Impact factor: 8.469

3.  Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy.

Authors:  Laura Torresano; Fulvio Santacatterina; Sonia Domínguez-Zorita; Cristina Nuevo-Tapioles; Alfonso Núñez-Salgado; Pau B Esparza-Moltó; Lucía González-Llorente; Inés Romero-Carramiñana; Cristina Núñez de Arenas; Brenda Sánchez-Garrido; Laura Nájera; Clara Salas; Mariano Provencio; José M Cuezva
Journal:  Oncogenesis       Date:  2022-05-09       Impact factor: 6.524

4.  Overexpression of Mitochondrial IF1 Prevents Metastatic Disease of Colorectal Cancer by Enhancing Anoikis and Tumor Infiltration of NK Cells.

Authors:  Lucía González-Llorente; Fulvio Santacatterina; Ana García-Aguilar; Cristina Nuevo-Tapioles; Sara González-García; Zuzana Tirpakova; María Luisa Toribio; José M Cuezva
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.